13F-HR filed by PERCEPTIVE ADVISORS LLC
PERCEPTIVE ADVISORS LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 116 holding rows worth $3,445,660,000.
- Accession
- 0001012975-22-000502
- Filer
- CIK 1224962
- Filed
- 2022-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 116 entries on the cover page, a total value of $3,445,660,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,445,660,000 with VALUE read as thousands by filing date, 13F file number 028-10438. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 27,372,917 | $285,773,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 2,784,796 | $194,490,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 6,511,727 | $184,021,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 2,322,247 | $158,145,000 | thousands by filing date | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 5,472,033 | $154,038,000 | thousands by filing date | |
| LIANBIO ADR | 53000N108 | COM | 57,558,451 | $115,116,000 | thousands by filing date | |
| CINCOR PHARMA INC | 17240Y109 | COM | 3,306,649 | $108,524,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 10,247,073 | $108,209,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 5,321,032 | $104,505,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 3,470,563 | $99,015,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 10,248,624 | $98,181,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 2,383,478 | $88,236,000 | thousands by filing date | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 1,468,512 | $86,657,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 2,122,535 | $76,624,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 11,350,085 | $60,609,000 | thousands by filing date | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 6,963,277 | $58,561,000 | thousands by filing date | |
| INHIBRX INC | 45720L107 | COM | 2,887,860 | $51,837,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 5,047,264 | $51,583,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 3,207,441 | $47,855,000 | thousands by filing date | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 2,465,405 | $46,276,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422GAA5 | CNV | 45,000,000 | $45,980,000 | thousands by filing date | principal |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 9,146,730 | $45,825,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 2,360,139 | $45,692,000 | thousands by filing date | |
| Veru Inc | 92536C103 | Common Stock | 3,893,000 | $44,847,000 | thousands by filing date | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,943,097 | $43,467,000 | thousands by filing date | |
| SEAGEN INC | 81181C104 | COM | 316,544 | $43,313,000 | thousands by filing date | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 1,713,134 | $41,218,000 | thousands by filing date | |
| VBI VACCINES INC | 91822J103 | COM NEW | 52,335,002 | $37,157,000 | thousands by filing date | |
| TREACE MED CONCEPTS INC | 89455T109 | COM | 1,601,979 | $35,356,000 | thousands by filing date | |
| NUVALENT INC COM | 670703107 | Stock | 1,655,007 | $32,173,000 | thousands by filing date | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 578,253 | $31,578,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 336,481 | $28,523,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 253,000 | $27,967,000 | thousands by filing date | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 330,000 | $27,268,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 4,400,099 | $27,060,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 10,933,387 | $26,568,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,220,575 | $25,034,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 366,400 | $25,025,000 | thousands by filing date | |
| IMMATICS N.V | N44445109 | SHS | 2,500,000 | $25,000,000 | thousands by filing date | |
| CAREMAX INC | 14171W103 | COM | 3,394,939 | $24,070,000 | thousands by filing date | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 1,296,416 | $22,194,000 | thousands by filing date | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 808,671 | $21,834,000 | thousands by filing date | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 331,023 | $21,513,000 | thousands by filing date | |
| NAUTILUS BIOTECHNOLOGY INC | 63909J108 | COM | 9,111,151 | $19,315,000 | thousands by filing date | |
| CYTEK BIOSCIENCES INC | 23285D109 | COMMON STOCK | 1,289,534 | $18,982,000 | thousands by filing date | |
| OUTSET MEDICAL INC | 690145107 | COM | 1,168,630 | $18,616,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 1,034,169 | $18,553,000 | thousands by filing date | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 411,804 | $18,239,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 666,477 | $17,435,000 | thousands by filing date | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 1,697,033 | $16,869,000 | thousands by filing date | |
| ARTIVION INC | 228903100 | COM | 1,204,229 | $16,667,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 1,667,123 | $16,021,000 | thousands by filing date | |
| VERRICA PHARMACEUTICALS INC | 92511W108 | COM | 5,038,983 | $14,714,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 430,000 | $14,642,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 2,150,641 | $14,409,000 | thousands by filing date | |
| ATHIRA PHARMA INC | 04746L104 | COM | 4,797,278 | $14,248,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 230,000 | $13,945,000 | thousands by filing date | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 687,424 | $13,941,000 | thousands by filing date | |
| HILLEVAX INC | 43157M102 | COM | 764,907 | $13,072,000 | thousands by filing date | |
| RAIN ONCOLOGY INC | 75082Q105 | COM | 2,483,619 | $12,120,000 | thousands by filing date | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 1,281,197 | $11,582,000 | thousands by filing date | |
| AXOGEN INC | 05463X106 | COM | 949,626 | $11,320,000 | thousands by filing date | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 263,720 | $10,934,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 100,050 | $10,626,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 363,197 | $10,278,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 192,680 | $9,954,000 | thousands by filing date | |
| LANDOS BIOPHARMA INC | 515069102 | CMN | 14,869,915 | $9,665,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 2,860,000 | $9,152,000 | thousands by filing date | |
| SINGULAR GENOMICS SYSTEMS IN | 82933R100 | COM | 3,536,274 | $8,841,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 500,000 | $7,980,000 | thousands by filing date | |
| KRONOS BIO INC | 50107A104 | COM | 2,156,151 | $7,223,000 | thousands by filing date | |
| ISOPLEXIS CORP | 465005106 | COM | 4,095,498 | $7,044,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 150,000 | $6,990,000 | thousands by filing date | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 766,231 | $6,720,000 | thousands by filing date | |
| LEAP THERAPEUTICS INC | 52187K101 | COM | 7,472,148 | $6,575,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 13,412,552 | $6,258,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 310,500 | $6,123,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 341,239 | $5,371,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 120,000 | $5,258,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 500,000 | $5,240,000 | thousands by filing date | put |
| INARI MED INC | 45332Y109 | COM | 70,000 | $5,085,000 | thousands by filing date | |
| ENVVENO MEDICAL CORPORATION | 29415J106 | COM | 781,615 | $4,909,000 | thousands by filing date | |
| SEMA4 HOLDINGS CORP | 81663L101 | COM | 5,000,000 | $4,390,000 | thousands by filing date | |
| SOMALOGIC INC | 83444K105 | COM | 1,500,000 | $4,350,000 | thousands by filing date | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 494,403 | $4,346,000 | thousands by filing date | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 735,165 | $4,279,000 | thousands by filing date | |
| ATHENEX INC | 04685N103 | COM | 15,532,467 | $4,178,000 | thousands by filing date | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 400,000 | $4,012,000 | thousands by filing date | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 500,000 | $3,865,000 | thousands by filing date | |
| HEALTH CATALYST INC | 42225T107 | COM | 389,962 | $3,783,000 | thousands by filing date | |
| NANOBIOTIX | 63009J107 | SPONSORED ADS | 1,059,800 | $3,752,000 | thousands by filing date | |
| COHERUS BIOSCIENCES INC | 19249HAB9 | BOND | 4,500,000 | $3,592,000 | thousands by filing date | principal |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 212,018 | $3,057,000 | thousands by filing date | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 1,528,812 | $3,012,000 | thousands by filing date | |
| ABSCI CORPORATION | 00091E109 | COM | 894,346 | $2,799,000 | thousands by filing date | |
| POSEIDA THERAPEUTICS INC | 73730P108 | COM | 750,000 | $2,648,000 | thousands by filing date | |
| CLOVER HEALTH INVESTMENTS CO | 18914F103 | COMMON STOCK | 1,500,000 | $2,550,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 100,000 | $2,513,000 | thousands by filing date | |
| QUOTIENT LTD | G73268107 | SHS | 16,200,818 | $2,430,000 | thousands by filing date | |
| SCIENCE 37 HOLDINGS INC | 808644108 | COM | 1,500,000 | $2,415,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 294,118 | $2,379,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 90,748 | $2,236,000 | thousands by filing date | |
| PEAR THERAPEUTICS INC | 704723105 | COM | 900,548 | $1,837,000 | thousands by filing date | |
| DARIOHEALTH CORP | 23725P209 | COM | 327,869 | $1,518,000 | thousands by filing date | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 290,051 | $859,000 | thousands by filing date | |
| HYPERFINE INC | 44916K106 | Common Stock | 927,388 | $751,000 | thousands by filing date | |
| SONENDO INC | 835431107 | Common Stocks | 612,204 | $655,000 | thousands by filing date | |
| PROVENTION BIO INC | 74374N102 | COM | 110,728 | $498,000 | thousands by filing date | |
| ICOSAVAX INC | 45114M109 | COM | 93,591 | $296,000 | thousands by filing date | |
| MOTUS GI HLDGS INC | 62014P405 | COM | 90,027 | $221,000 | thousands by filing date | |
| EQRX INC | 26886C115 | *W EXP 12/17/202 | 250,000 | $205,000 | thousands by filing date | |
| AGILE THERAPEUTICS INC | 00847L209 | COM NEW | 532,361 | $158,000 | thousands by filing date | |
| CAREMAX INC | 14171W111 | *W EXP 06/08/202 | 60,000 | $113,000 | thousands by filing date | |
| NEPTUNE WELLNESS SOLUTIONS I | 64079L204 | COM NEW | 57,142 | $87,000 | thousands by filing date | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 166,666 | $31,000 | thousands by filing date | |
| Surrozen, Inc. | 86889P109 | COM | 6,017 | $12,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-22-000502 | this filing | 2022-11-14 | acceptance time not in the bulk data set |